The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and

Masoud Rahmati1, Ai Koyanagi2,3,4, Ebrahim Banitalebi5

  • 1Department of Physical Education and Sport Sciences, Faculty of Literature and Human Sciences, Lorestan University, Khoramabad, Iran.

Journal of Medical Virology
|November 19, 2022
PubMed

Insights

COVID-19 survivors show persistent cardiac dysfunction, including reduced ejection fraction and increased left ventricular mass, even one year post-infection. These cardiovascular changes are more pronounced in patients with severe acute SARS-CoV-2 infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Longitudinal effects of SARS-CoV-2 on cardiac structure and function remain unclear.
  • Understanding post-COVID-19 cardiovascular sequelae is crucial for patient management and public health strategies.

Approach:

  • Systematic review and meta-analysis of 21 studies (2394 individuals) published up to August 2022.
  • Pooled analysis of cardiac structure and function outcomes in COVID-19 survivors compared to controls.
  • Subgroup analysis based on COVID-19 severity (acute phase) and chronic outcomes.

Key Points:

  • Post-COVID-19 associated with reduced left ventricular ejection fraction, end-diastolic volume, stroke volume, mitral annular plane systolic excursion, global longitudinal strain, and right ventricular function.
  • Increased left ventricular mass observed in COVID-19 survivors.
  • Cardiac impairment persisted beyond one year, particularly in patients with a history of intensive care unit admission.

Conclusions:

  • SARS-CoV-2 infection leads to significant and persistent cardiac dysfunction in recovered individuals.
  • Severity of acute COVID-19 influences the extent of long-term cardiac impairment.
  • Further research is needed to elucidate the underlying biological mechanisms of these cardiovascular consequences.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
30
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
766
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23